Post-vaccination embolic and thrombotic events, termed vaccine-induced immune thrombotic thrombocytopenia (VITT), vaccine-induced prothrombotic immune... 51 KB (5,052 words) - 19:27, 11 March 2024 |
such as the AstraZeneca and Johnson & Johnson vaccines due to the rare risk of post-vaccination embolic and thrombotic events, with vice-chairman Shelly... 166 KB (13,886 words) - 09:34, 8 March 2024 |
phase III trials, and 9 in phase IV development. Post-vaccination embolic and thrombotic events, termed vaccine-induced immune thrombotic thrombocytopenia... 192 KB (21,930 words) - 19:29, 15 April 2024 |
citing the risk of post-vaccination embolic and thrombotic events in the current context of readily available mRNA vaccines (Pfizer and Moderna), which do... 150 KB (8,473 words) - 05:20, 15 October 2023 |
Oxford-AstraZeneca vaccine and its potential side-effects of blood clots in post-vaccination embolic and thrombotic events. Due to recommendations from... 38 KB (3,134 words) - 00:37, 19 September 2023 |
AstraZeneca (category COVID-19 vaccine producers) blood clots with lowered blood platelets, see embolic and thrombotic events after COVID-19 vaccination. The temporary halt was against the advice of the... 85 KB (7,811 words) - 21:10, 17 April 2024 |
that a case of post-vaccination embolic and thrombotic events had been diagnosed in a patient who received the AstraZeneca vaccine, and that the province... 257 KB (22,391 words) - 20:38, 21 December 2023 |
citing the risk of post-vaccination embolic and thrombotic events in the current context of readily available mRNA vaccines (Pfizer and Moderna), which do... 214 KB (21,201 words) - 14:59, 26 March 2024 |